Search Home
Search Home
Our Team
Search Home
Search Home
Search Home

Mark E. Sutter, M.D. View profile as PDF

Mark E. Sutter

Clinical Interests

Dr. Sutter's clinical interest focuses on poisonings and overdoses particularly in critically ill patients. Dr. Sutter is interested in pesticide toxicity and cardiovascular medication toxicity.


Associate Professor
Toxicology Fellowship Director


Emergency Medicine



Emergency Medicine


UC Davis Medical Center
Emergency Medicine Department
2315 Stockton Blvd.
Sacramento, CA 95817
Driving Directions
Phone: 916-734-3790

Additional Phone:

Physician Referrals: 800-4-UCDAVIS (800-482-3284)


M.D., University of Vermont College of Medicine, Burlington, Vermont, 2002
B.S., UCLA, Los Angeles, California, 1997


University of California, Davis, Sacramento, CA, 2006


University of California, Davis, Sacramento, CA, 2005


Emory-Centers for Disease Control, Atlanta, GA, 2008

Board Certifications:

American Board of Emergency Medicine, 2006
American Board of Medical Toxicology, 2008

Professional Memberships:

American Association of Clinical Toxicology
American Association of Medical Toxicology
American College of Emergency Physicians
Society of Academic Emergency Medicine

Select Recent Publications:

Sutter ME, Turnipseed S, Samuel P, White R. The use of ultrasound for lower extremity venous thrombosis: The incidence of alternative findings. Manuscript accepted by Journal of Emergency Medicine. Abstract published and presented at the Society for Academic Emergency Medicine Conference, New York City, May 2005.

Sutter ME, Diercks D. Management of acute decompensated heart failure. Clinical Bulletin, Sterling Healthcare, March 2005, Limited distribution for CME accreditation.

Sutter ME, Diercks D. New insights into decompensated heart failure. Emergency Medicine, 2005; 37 (6): 18-25.

Sutter ME, Diercks D. Review of JAMA article. Does this patient have a torn meniscus or ligament of the knee? Value of the physical examination. Lifeline. March 2004; 24. Original article, JAMA, 2001; 286: 1610-1620.

Freedland SJ, Sutter ME, Dorey F, Aronson WJ. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Urology, 2003; 61(2); 365-369.

Freeland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology. 2000; 56(1): 87-91.

Freeland SJ, Sutter ME, Naitoh J, Dorey F, Csathy GS, Aronson WJ. Clinical characteristics in black and white men with prostate cancer in an equal access medical center. Urology. 2000; 55(3): 387-390.

Search Home